Therapeutic Potential of Gamma Entrainment Using Sensory Stimulation for Cognitive Symptoms Associated with Schizophrenia

Tallan Black,Bryan W. Jenkins,Robert B. Laprairie,John G. Howland
DOI: https://doi.org/10.1016/j.neubiorev.2024.105681
IF: 9.052
2024-04-18
Neuroscience & Biobehavioral Reviews
Abstract:Schizophrenia is a complex neuropsychiatric disorder with significant morbidity. Treatment options that address the spectrum of symptoms are limited, highlighting the need for innovative therapeutic approaches. Gamma Entrainment Using Sensory Stimulation (GENUS) is an emerging treatment for neuropsychiatric disorders that uses sensory stimulation to entrain impaired oscillatory network activity and restore brain function. Aberrant oscillatory activity often underlies the symptoms experienced by patients with schizophrenia. We propose that GENUS has therapeutic potential for schizophrenia. This paper reviews the current status of schizophrenia treatment and explores the use of sensory stimulation as an adjunctive treatment, specifically through gamma entrainment. Impaired gamma frequency entrainment is observed in patients, particularly in response to auditory and visual stimuli. Thus, sensory stimulation, such as music listening, may have therapeutic potential for individuals with schizophrenia. GENUS holds novel therapeutic potential to improve the lives of individuals with schizophrenia, but further research is required to determine the efficacy of GENUS, optimize its delivery and therapeutic window, and develop strategies for its implementation in specific patient populations.
behavioral sciences,neurosciences
What problem does this paper attempt to address?